Pharmacokinetic analysis of ceftazidime and cefazolin in the treatment of continuous ambulatory peritoneal dialysis-related peritonitis
Objective Peritoneal dialysis-related peritonitis (PDRP) presents a significant challenge for nephrologists. Continuous intraperitoneal cefazolin and ceftazidime are recommended for the treatment of peritonitis. However, some pharmacokinetic studies have shown that doses of 15–20 mg/kg/d may not ach...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2023-12-01
|
| Col·lecció: | Renal Failure |
| Matèries: | |
| Accés en línia: | https://www.tandfonline.com/doi/10.1080/0886022X.2023.2285873 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|